First, cancer creates a state of hypercoagulability through several mechanisms: tumor cells can produce and release large amounts of TF, causing an increase in inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and interleukin (IL)-1β, and blood vessels can be directly damaged by therapeutic mechanisms, such as chemotherapy and radiotherapy [9]. The gene discussed is TF; the disease is neoplasm.